PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Shifting Perspectives in the Management of Schizophrenia: Impacting Outcome Through Early Use of Long-Acting Injectables
Visit https://www.peervoice.com/YDM860 to view the entire programme with slides. After completing “Shifting Perspectives in the Management of Schizophrenia: Impacting Outcome Through Early Use of Long-Acting Injectables”, participants will be able to: Recognize the importance of using long-acting injectable (LAI) antipsychotics in early-stage schizophrenia; Examine the risk-benefit profiles of second-generation LAI antipsychotics in early-stage schizophrenia and how these may translate to patient care.